Inclisiran vs bempedoic acid for low-density lipoprotein cholesterol lowering in high-risk patients: the VICTORION-challenge trial

Ingo Hilgendorf, Dirk Westermann, Bernd Nowak, Peter Uebel, Martin Dürsch, Amir A Mahabadi, Gregor Nagel, Uwe Gerbaulet, Simone Hiltl, Mirjam Metzner, Margarita Pruckner, Patrick Schwaferts, Jan-Hendrik Streich, Daniel Thieme, Anne Groß-Bsharat, Wolfgang Koenig, Ulf Landmesser

Open source

DOI: 10.1093/eurheartj/ehag738
Published: 2026-08-31
Container: European Heart Journal
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehag738,
  title = {Inclisiran vs bempedoic acid for low-density lipoprotein cholesterol lowering in high-risk patients: the VICTORION-challenge trial},
  author = {Ingo Hilgendorf and Dirk Westermann and Bernd Nowak and Peter Uebel and Martin Dürsch and Amir A Mahabadi and Gregor Nagel and Uwe Gerbaulet and Simone Hiltl and Mirjam Metzner and Margarita Pruckner and Patrick Schwaferts and Jan-Hendrik Streich and Daniel Thieme and Anne Groß-Bsharat and Wolfgang Koenig and Ulf Landmesser},
  year = {2026},
  journal = {European Heart Journal},
  doi = {10.1093/eurheartj/ehag738},
  url = {https://doi.org/10.1093/eurheartj/ehag738}
}

RIS

TY  - JOUR
TI  - Inclisiran vs bempedoic acid for low-density lipoprotein cholesterol lowering in high-risk patients: the VICTORION-challenge trial
AU  - Ingo Hilgendorf
AU  - Dirk Westermann
AU  - Bernd Nowak
AU  - Peter Uebel
AU  - Martin Dürsch
AU  - Amir A Mahabadi
AU  - Gregor Nagel
AU  - Uwe Gerbaulet
AU  - Simone Hiltl
AU  - Mirjam Metzner
AU  - Margarita Pruckner
AU  - Patrick Schwaferts
AU  - Jan-Hendrik Streich
AU  - Daniel Thieme
AU  - Anne Groß-Bsharat
AU  - Wolfgang Koenig
AU  - Ulf Landmesser
PY  - 2026
JO  - European Heart Journal
DO  - 10.1093/eurheartj/ehag738
UR  - https://doi.org/10.1093/eurheartj/ehag738
ER  -

APA

Hilgendorf, I., Westermann, D., Nowak, B., Uebel, P., Dürsch, M., Mahabadi, A. A., Nagel, G., Gerbaulet, U., Hiltl, S., Metzner, M., Pruckner, M., Schwaferts, P., Streich, J., Thieme, D., Groß-Bsharat, A., Koenig, W., & Landmesser, U. (2026). Inclisiran vs bempedoic acid for low-density lipoprotein cholesterol lowering in high-risk patients: the VICTORION-challenge trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehag738

Source records

crossref · retrieved 2026-09-26T15:23:19.555Z